2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Abstract Number: 2712

Nailfold Videocapillaroscopy in Healthy Children and Adolescents: Description of Patterns of Normality
Abstract Number: 1926

Nailfold Videocapillaroscopy Patterns Associated with Calcinosis and Acro-Osteolysis in Systemic Sclerosis
Abstract Number: 1856

National Hospitalization Trends in Lupus Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Infections
Abstract Number: 1832

National Quality Forum Measure Achievement and Costs in Rheumatoid Arthritis Patients in a Large Managed Care Population
Abstract Number: 205

Natural History and Clinical Significance of Meniscal Tears over 8 Years in a Largely Non-Osteoarthritic Cohort
Abstract Number: 277

Nearly 20% of Children ARE NOT Correctly Classified According to Current ILAR Classification in a Printo Dataset of More THAN 12,000 Juvenile Idiopathic Arthritis Patients
Abstract Number: 3012

Needs Assessment Survey – Evaluation of Sexual Dysfunction Among Patients at a Tertiary Rheumatology Clinic
Abstract Number: 815

Netosis Induced Histone Citrullination Facilitates Onset and Propagation of Rheumatoid Arthritis
Abstract Number: 24

Netrin1 Is Highly Expressed and Required in Inflammatory Infiltrates in Wear Particle-Induced Osteolysis
Abstract Number: 392

Neuroendocrine Hormone and Metabolic Peptide Levels in the Earliest Phases of Rheumatoid Arthritis – Do Free Fatty Acids Play a Role?
Abstract Number: 2659

Neurofilament H Is Associated with White Matter Lesions in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1170

Neurological Complications during Anti-TNF Therapy: A Prospective Imaging and Electrophysiological Study
Abstract Number: 246

Neuropathic PAIN in Patients with Ankylosing Spondylitis
Abstract Number: 1941

Neuropsychiatric Lupus Is Substantially Unaffected By B-Cell Deficiency
Abstract Number: 1969

Neurotrophin Receptor p75 (CD271) Defines a Distinct Synovial Fibroblast Subset in Rheumatoid and Osteoarthritic Synovial Tissues with Enhanced Proinflammatory Potential
Abstract Number: 1032

Neutralization of IL-17 Ameliorated Kidney Pathology Associated with Immune-Complex Mediated Autoimmune Glomerulonephritis
Abstract Number: 1593

Neutrophil-Lymphocyte Ratio As a Marker of Disease Activity in Psoriatic Arthritis
Abstract Number: 1610

New Autoantigens Associated with Lupus Nephritis
Abstract Number: 2898

New Insights into the Primary Care Osteoarthritis Consultation with Implications for Practice
Abstract Number: 2204

New Onset Vitiligo Under Biological Agents: A Case Series
Abstract Number: 314

Next Generation Sequencing Reveals Restriction of the Treg Cell Repertoire and an Abundance of Shared Synovial Treg Clonotypes in JIA
Abstract Number: 1960

NF-κB-Inducing Kinase (NIK) Is Expressed in Synovial Endothelial Cells in Early Arthritis Patients and Correlates with Local Disease Activity and Systemic Markers of Inflammation
Abstract Number: 1203

NK/NKT Cells from Early and Definite Systemic Sclerosis Patients Show Different Immunological Responses after IL-2 Stimulation
Abstract Number: 315

NLRC4-Related Macrophage Activation Syndrome (NLRC4-MAS): A Novel Primary Autoinflammatory Syndrome Caused By Activating Mutations in NLRC4
Abstract Number: 2047

No Association of Serum Uric Acid with Hip Fracture Risk in Older Men and Women from the Framingham Original Cohort
Abstract Number: 2617

No Evidence of Accelerated Atheromatosis, Increased Arterial Stiffness or Hypertrophy in Ankylosing Spondylitis: A Systematic Case-Control Study
Abstract Number: 1838

No Increased Risk of Developing a First Invasive Melanoma in Rheumatoid Arthritis Patients Treated with Biologics: Results of a Collaborative Project of 11 European Biologics Registers
Abstract Number: 832

NOD2-Associated Autoinflammatory Disease: The Largest Cohort Study
Abstract Number: 2399

Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
Abstract Number: 2802

Non-Canonical NF-Kappab Signaling Promotes Angiogenesis in a Novel 3D Spheroid Model of Rheumatoid Arthritis Synovial Inflammation
Abstract Number: 12

Non-Criteria Antiphospholipid Antibodies in Obstetrical “seronegative Anti-Phospholipid syndrome”
Abstract Number: 582

Non-Steroidal Anti-Inflammatory Drugs in Axial Spondyloarthritis: A Cochrane Review
Abstract Number: 2778

Non-Systemic Vasculitic Neuropathy: Presentation, Therapeutic Management and Outcome
Abstract Number: 1420

Non-Use of Glucocorticoid and Osteoarthritis Absence As Predictors of Clinical Remission in AR
Abstract Number: 2635

Noncalcified Plaque Progression in Systemic Lupus Erythematosus
Abstract Number: 2105

Nonsurgical Treatment Patterns in Patients with Chronic Spinal Cord Injury
Abstract Number: 417

Normal Scores of “0” (floor effects) Are Seen in 33-83% of Patients with Rheumatoid Arthritis (RA) on 8 HAQ Activities Which Also Are Found on the MDHAQ, but in Fewer Than 32% of Patients on 2 Unique MDHAQ Complex Activities “Walk 2 Miles or 3 Kilometers,” and “Participate in Recreation and Sports.”
Abstract Number: 1573

Norwegian Psoriatic Arthritis Patients Are More Obese Than Rheumatoid Arthritis and Axial Spondyloarthropathy Patients
Abstract Number: 1855

Not Keeping up with the Times: High Mortality and Early Death Due to Disease in North American Natives with Systemic Lupus Erythematosus (SLE)
Abstract Number: 1149

Novel Adherence Measures for Infusible Therapeutic Agents in Rheumatoid Arthritis
Abstract Number: 987

Novel Auto-Antigen in Aortic Aneurysms of Large Vessel Vasculitis
Abstract Number: 2209

Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in UC and CD
Abstract Number: 1044

Novel Compound Cytokine Release Inhibitory Drug 3 (CRID3) Inhibits the NLRP3 Inflammasome in Rheumatoid Arthritis
Abstract Number: 2877

Novel Function of Tocilizumab As a Modulator of Interleukin-27-Mediated Anti-Inflammatory Responses
Abstract Number: 784

Novel Inhibitory Effects of Mast Cells in Aortitis Involves Aortic Expression of Suppressor of Cytokine Signaling-1
Abstract Number: 1178

Novel Quantification of MRI Provides a More Sensitive Outcome Measure Than Ramris
Abstract Number: 1664

Novel Risk Factors for Systemic Lupus Erythematosus (SLE) Flares in Patients with End-Stage Renal Disease: Is SLE in Patients with End-Stage Renal Disease a “sleeping beauty”?
Abstract Number: 1207

Novel Role of Liver X Receptor Alpha (LXRα) in the Attenuation of TLR Signalling: Implications in Congenital Heart Block
Abstract Number: 780

Novel Roles for Zyxin in the Pathogenesis of Giant Cell Arteritis
Abstract Number: 2979

Nucleic Acid Sensing Receptors TLR7, RIG-I and MDA5 Collaborate in Driving the Systemic IFN Signature and Amplify the Pathogenic Loop: Potential New Targets for Therapy in Primary Sjogrens Syndrome
Abstract Number: 756

Nucleosome, a Basic Repeating Unit of Chromatin, in Patients with Systemic Sclerosis: Possible Association with Immunological Abnormalities Via Abnormal Activation of T and B Cells
Abstract Number: 1464

Numbers of Circulating CD4 Positive CD28null T Cells Are Increased in Patients with Rheumatoid Arthritis and Are Associated with Rheumatoid Factor Positivity but Not Subclinical Cardiovascular Disease
Abstract Number: 1101

Numbness and Tingling: Neurological Symptoms in Fibromyalgia
Abstract Number: 263

Nutraceutical Products and Pain or Non-Pain Medications Use in Patients with Knee Osteoarthritis
Abstract Number: 2432

Nutritional Assessment in Patients with Systemic Lupus Erythematosus and Systemic Sclerosis

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].